Using cyclodextrins in the textile industry

today’s cyclodextrin:
I brought some applications from the textile industry. Interestingly, there are no real successful commercial examples (that I know of, at least) using CDs in the textile industry. Yet there are so many inventions in the field, I am sure, this is just a matter of time. These two applications are both interesting, on is and ultraviolet-resistant application, the other is a flame-retardant material.

Flame-retardant non-woven fabric and preparation process

Anti-ultraviolet multifunctional textile fiber material and preparation method thereof

Live Q&A on Cyclodextrins

Breaking News: Live LinkedIn Q&A Session on Cyclodextrins Unveils Insights from Industry Experts!

Join us for an exclusive live event on LinkedIn as we delve into the fascinating world of cyclodextrins! This dynamic Q&A session brings together industry experts, researchers, and enthusiasts to explore the diverse applications and cutting-edge advancements in the field of cyclodextrin science.

📅 Date & Time: January 23, 2024 14.00 CET

📍 Location: LinkedIn Live – https://www.linkedin.com/events/7150478953097469953/?lipi=urn%3Ali%3Apage%3Ad_flagship3_company_admin%3BUXLAZXmBRdGB89QgeEFQdA%3D%3D

What to Expect:

  1. Insider Insights: Gain a deeper understanding of cyclodextrins and their versatile applications across various industries, from pharmaceuticals to food and beyond.
  2. Expert Panel: Engage with a panel of distinguished experts who will share their knowledge, experiences, and perspectives on the latest developments in cyclodextrin research.
  3. Interactive Q&A: Pose your burning questions directly to the experts during the live session. Get real-time answers and insights that matter to you.
  4. Networking Opportunities: Connect with like-minded professionals, researchers, and industry leaders who share a passion for cyclodextrin science.

How to Participate:

  • Follow our LinkedIn page to receive notifications and updates about the live event.
  • Set a reminder for the scheduled date and time to ensure you don’t miss out on this unique opportunity.
  • Prepare your questions in advance to make the most of the interactive Q&A session.

Who Should Attend:

  • Researchers and scientists in the fields of chemistry, pharmaceuticals, and materials science.
  • Professionals in industries utilizing cyclodextrins, including pharmaceuticals, food and beverages, cosmetics, and more.
  • Students and academics interested in gaining insights into the latest advancements in cyclodextrin research.

Don’t miss this chance to be part of a vibrant community discussing the groundbreaking advancements in cyclodextrin science! Mark your calendars and join us for an engaging and informative live Q&A session.

Stay tuned for more updates and surprises during the event! 🚀

If you follow us, you know that we are keen to spread the word about cyclodextrins and create educational content. Now, we would like to get closer to you and answer any questions you may have directly. Formulation, analysis, chemistry, business, future applications, everything is on the table.

Feel free to join and ask directly from our CEO, Tamas Sohajda.

You can register and learn more here: 

📍 Location: LinkedIn Live – https://www.linkedin.com/events/7150478953097469953/?lipi=urn%3Ali%3Apage%3Ad_flagship3_company_admin%3BUXLAZXmBRdGB89QgeEFQdA%3D%3D

Cyclodextrin supramolecular drug for targeted delivery of camptothecin as well as preparation method and application of cyclodextrin supramolecular drug

We believe that using cyclodextrin for targeted delivery of molecules is certainly one of the applications that will be in future’s research focus.

In this patent that we bring today as a good example, a camptothecin derivative and cyclodextrin polyrotaxane are subjected to a click chemical reaction under the catalysis of copper, and the cyclodextrin supramolecular drug for targeted delivery of camptothecin is obtained by using active folate termination. Cell experiments show that the compound has good targeting selectivity and anti-tumor effect, and also has the advantage of small toxic and side effects.

Espacenet – Cyclodextrin supramolecular drug for targeted delivery of camptothecin as well as preparation method and application of cyclodextrin supramolecular drug

The world’s top 400 companies for women

As women continue to return to the workforce following a decline during the Covid pandemic, many companies know that to attract top female talent they need to offer benefits like family leave options as well as other opportunities for women’s empowerment on the job. For Forbes’ ranking of the World’s Top Companies for Women 2023, we looked at the companies that are excelling in these areas. Check out the list below, and then keep reading for stories on “energy vampires” at the office, bridge jobs and more.

World’s Top Companies for Women 2023 (forbes.com)

Antimony and naphthalene can be simultaneously leached from a combined contaminated soil using carboxymethyl-β-cyclodextrin as a biodegradable eluant

today’s cyclodextrin:
The use of CDs in soil remediation has a long history. Here is the most recent chapter.
The removal efficiency of antimony (Sb) and naphthalene (Nap) from a combined contaminated soil was studied by carboxymethyl-β-cyclodextrin (CMCD) leaching and reveal its remediation mechanisms. The results show that the highest removal efficiencies of Sb and Nap were 94.82% and 93.59%, respectively. The breakthrough curves show that CMCD had a stronger inclusion capacity of Nap than Sb, and Sb could enhance the adsorption capacity of Nap, while Nap weakened the adsorption of Sb during CMCD leaching. CMCD is a good eluant for remediating soil contaminated by a combination of heavy metals and polycyclic aromatic hydrocarbons (PAHs), and its remediation mechanisms depend on the complexation reactions between the surface functional groups and inclusion reactions in the internal cavities.

See the full article here

Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation

A very recent patent application from ASDERA on using hyproxypropyl-alfa-cyclodextrin formulated with a medium chain fatty acid (ideally a cproic acid derivative) for the ORAL delivery is the CD. Similarly to our interests, the CD itself is proposed to be the therapeutic agent and the oral delivery would open a new solution to treat cancer or a neurodegenerative, cardiovascular, metabolic, inflammatory, autoimmune, age-related, or viral disease or disorder in a subject which is currently only possible via parenteral administration. Keep an eye on Knut M. Wittkowski as his research is highly important. Overcoming the current issues with CD dosing is an unsolved problem in this research area.

See the full patent here: Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation